KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Sarepta Therapeutics (SRPT) over the last 14 years, with Q2 2025 value amounting to $2.01.

  • Sarepta Therapeutics' EPS (Basic) rose 277142.86% to $2.01 in Q2 2025 from the same period last year, while for Jun 2025 it was $4.1, marking a year-over-year increase of 400000.0%. This contributed to the annual value of $2.47 for FY2024, which is 14258.62% up from last year.
  • Latest data reveals that Sarepta Therapeutics reported EPS (Basic) of $2.01 as of Q2 2025, which was up 277142.86% from $1.67 recorded in Q4 2024.
  • In the past 5 years, Sarepta Therapeutics' EPS (Basic) ranged from a high of $2.01 in Q2 2025 and a low of -$1203.7 during Q1 2022
  • Its 5-year average for EPS (Basic) is -$80.77, with a median of -$0.6 in 2021.
  • In the last 5 years, Sarepta Therapeutics' EPS (Basic) tumbled by 5721826.39% in 2022 and then surged by 277142.86% in 2025.
  • Sarepta Therapeutics' EPS (Basic) (Quarter) stood at -$1.43 in 2021, then grew by 13.29% to -$1.24 in 2022, then surged by 161.29% to $0.76 in 2023, then surged by 119.74% to $1.67 in 2024, then rose by 20.36% to $2.01 in 2025.
  • Its EPS (Basic) stands at $2.01 for Q2 2025, versus $1.67 for Q4 2024 and $0.36 for Q3 2024.